|
1
|
World Health Organization: Global
tuberculosis report. 2019, Geneva: World Health Organization,
2019.
|
|
2
|
Chen W, Cheng S and Wang L: Incidence of
pulmonary tuberculosis reported by national notifiable communicable
diseases surveillance system, 1997-2008. Disease Surveillance.
24:878–881. 2009.
|
|
3
|
The report of the Data-Center of China
Public Health Science. http://www.phsciencedata.cn/Share/en/index.jsp.
|
|
4
|
Wu B, Yu Y, Xie W, Liu Y, Zhang Y, Hu D
and Li Y: Epidemiology of tuberculosis in Chongqing, China: A
secular trend from 1992 to 2015. Sci Rep. 7(7832)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Technical Guidance Group for the Fifth
National TB Epidemiological Survey. The fifth national tuberculosis
epidemiological survey in 2010. Chin J Antituberculosis.
34:485–508. 2012.
|
|
6
|
Liao Z, Zhang X, Zhang Y and Peng D:
Seasonality and trend forecasting of tuberculosis incidence in
Chongqing, China. Interdiscip Sci. 11:77–85. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wu B, Yu Y, Du C, Liu Y and Hu D:
Epidemiology of drug-resistant tuberculosis in Chongqing, China: A
retrospective observational study from 2010 to 2017. PLoS One.
14(e0216018)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Khvilivitzky K, Trivedi PN and McFadden
PM: Tuberculous tracheobronchial stenosis: Avoiding resection-when
less is more. J Thorac Dis. 9:E779–E782. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kashyap S and Solanki A: Challenges in
endobronchial tuberculosis: From diagnosis to management. Pulm Med.
2014(594806)2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shim YS: Endobronchial tuberculosis.
Respirology. 1:95–106. 1996.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Um SW, Yoon YS, Lee SM, Yim JJ, Yoo CG,
Chung HS, Kim YW, Han SK, Shim YS and Kim DK: Predictors of
persistent airway stenosis in patients with endobronchial
tuberculosis. Int J Tuberc Lung Dis. 12:57–62. 2007.PubMed/NCBI
|
|
12
|
Jung SS, Park HS, Kim JO and Kim SY:
Incidence and clinical predictors of endobronchial tuberculosis in
patients with pulmonary tuberculosis. Respirology. 20:488–495.
2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Su Z, Cheng Y, Wu Z, Zhang P, Chen W, Zhou
Z, Zhong M, Luo W, Guo W and Li S: Incidence and predictors of
tracheobronchial tuberculosis in pulmonary tuberculosis: A
multicentre, large-scale and prospective study in southern China.
Respiration. 97:153–159. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chinese Medical Association. Diagnosis and
treatment guideline for tracheobronchial tuberculosis. Chin J
Tuberc Respir Dis. 35:581–587. 2012.
|
|
15
|
Kubica GP, Dye WE, Cohn ML and Middlebrook
G: Sputum digestion and decontamination with
N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria.
Am Rev Respir Dis. 87:775–779. 1963.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Helb D, Jones M, Story E, Boehme C,
Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, et al: Rapid
detection of Mycobacterium tuberculosis and rifampin resistance by
use of on-demand, near-patient technology. J Clin Microbiol.
48:229–237. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ozkaya S, Bilgin S, Findik S, Kok HC,
Yuksel C and Atici AG: Endobronchial tuberculosis:
Histopathological subsets and microbiological results. Multidiscip
Respir Med. 7(34)2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang Q, Zhang Q, Sun BQ, Liu C, Su AN,
Wang XH, Liu N, Zhang J, Kang J and Hou G: GeneXpert MTB/RIF for
rapid diagnosis and rifampin resistance detection of endobronchial
tuberculosis. Respirology. 23:950–955. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
World Health Organization. Xpert MTB/RIF
assay for the diagnosis TB: meeting report, 2016. WHO Press, 1211
Geneva 27, Switzerland.Report No: WHO/HTM/TB/2016.19.
|
|
20
|
Nakamoto K and Maeda M:
Tracheobronchoplasty for endobronchial tuberculosis. Kekkaku.
66:789–792. 1991.PubMed/NCBI(In Japanese).
|
|
21
|
National Tuberculosis Association of USA:
Diagnostic Standards and Classification of Tuberculosis. National
Tuberculosis Association, New York, NY, 1961.
|
|
22
|
Möller M, Kinnear CJ, Orlova M, Kroon EE,
van Helden PD, Schurr E and Hoal EG: Genetic Resistance to
Mycobacterium tuberculosis genetic resistance to infection
and disease. Front Immunol. 9(2219)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Abel L, Fellay J, Haas DW, Schurr E,
Srikrishna G, Urbanowski M, Chaturvedi N, Srinivasan S, Johnson DH
and Bishai WR: Genetics of human susceptibility to active and
latent tuberculosis: Present knowledge and future perspectives.
Lancet Infect Dis. 18:e64–e75. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Möller M and Kinnear CJ: Human global and
population-specific genetic susceptibility to Mycobacterium
tuberculosis infection and disease. Curr Opin Pulm Med. 26:302–310.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Dong C: Differentiation and function of
pro-inflammatory Th17 cells. Microbes Infect. 11:584–588.
2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Khader SA, Bell GK, Pearl JE, Fountain JJ,
Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL,
et al: IL-23 and IL-17 in the establishment of protective pulmonary
CD4+T cell responses after vaccination and during
Mycobacterium tuberculosis challenge. Nat Immunol. 8:369–377.
2007.PubMed/NCBI View
Article : Google Scholar
|
|
27
|
Chen X, Zhang M, Zhu X, Deng Q, Liu H,
Larmonier N, Graner MW and Zhou B: Engagement of toll-like receptor
2 on CD4(+) T cells facilitates local immune responses in patients
with tuberculous pleurisy. J Infect Dis. 200:399–408.
2009.PubMed/NCBI View
Article : Google Scholar
|
|
28
|
Strawbridge HD, Lin Y, Rangel-Moreno J,
Ritchea S, Logar A, Randall T, Kolls J and Khader S: IL-17 is
critical for the generation of protective vaccine-induced immunity
against tuberculosis. Am J Respir Crit Care Med.
179(A5910)2009.
|
|
29
|
Kimura A and Kishimoto T: IL-6: Regulator
of Treg/Th17 balance. Eur J Immunol. 40:1830–1835. 2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Georgiadou P and Sbarouni E: Effect of
hormone replacement therapy on inflammatory biomarkers. Adv Clin
Chem. 47:59–93. 2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Park IW, Choi BW and Hue SH: Prospective
study of corticosteroid as an adjunct in the treatment of
endobronchial tuberculosis in adults. Respirology. 2:275–281.
1997.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Sucena M, Amorim A, Machado A, Hespanhol V
and Magalhães A: Endobronchial tuberculosis-clinical and
bronchoscopic features. Rev Port Pneumol. 10:383–391.
2004.PubMed/NCBI View Article : Google Scholar : (In Portuguese).
|
|
33
|
Hoheisel G, Chan BK, Chan CH, Chan KS,
Teschler H and Costabel U: Endobronchial tuberculosis: Diagnostic
features and therapeutic outcome. Respir Med. 88:593–597.
1994.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Guo X, Wang C, Wang X, Ma J, Xv L, Luan T
and Kou C: Characteristics and risk factor analysis of 410 cases of
tracheobronchial tuberculosis. Exp Ther Med. 8:781–784.
2014.PubMed/NCBI View Article : Google Scholar
|
